Dirakwaranon Witchapone, Suwannarurk Komsun, Chitkoolsamphan Yanwadee, Wisarnsirirak Pattra, Bhamarapravatana Kornkarn, Pattaraarchachai Junya
Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand.
Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
Asian Pac J Cancer Prev. 2024 Dec 1;25(12):4391-4396. doi: 10.31557/APJCP.2024.25.12.4391.
Aim of the study was to evaluate and compare the prevalence female sexual dysfunction (FSD) in cervical cancer (CC) survivors to a healthy female population.
This observational prospective trial was conducted at Thammasat University Hospital, Thailand, between April 2023 and February 2024. Participants were CC survival who attended an outpatient cancer clinic. Subject with age between 30 and 60 years old and engaged in sexual intercourse at least once within the last 4 weeks were recruited. The control group was women who attended outpatient gynecologic clinic for routine pelvic examination with no serious medical diseases and no malignancy. The female sexual function index (FSFI) was applied to all the participants during the survey. Other demographic data of the participants were collected.
A total of 116 cases were enrolled in the study. Participants were equally divided into the study and control groups. The mean age and BMI of participants were 49.4 years and 24.7 kg/m², respectively without statistical significance. The FSD's prevalence of the CC survival was significantly higher than control group (34.5 and 10.4 percent, respectively). CC survivors reported significantly poorer outcomes in the domains of lubrication, sexual satisfaction, and pain compared to the control group.
The prevalence rates of CC survival and control group was 34.5 and 10.4 percent, respectively. Three out of six FSFI domains namely lubrication, satisfaction, and pain showed more problematic for CC survivors compared to control group.
本研究旨在评估并比较宫颈癌（CC）幸存者与健康女性群体中女性性功能障碍（FSD）的患病率。
这项观察性前瞻性试验于2023年4月至2024年2月在泰国法政大学医院进行。参与者为前往癌症门诊就诊的CC幸存者。招募年龄在30至60岁之间且在过去4周内至少有过一次性交的受试者。对照组为前往妇科门诊进行常规盆腔检查且无严重疾病和恶性肿瘤的女性。在调查期间，对所有参与者应用女性性功能指数（FSFI）。收集参与者的其他人口统计学数据。
本研究共纳入116例病例。参与者被平均分为研究组和对照组。参与者的平均年龄和体重指数分别为49.4岁和24.7kg/m²，无统计学意义。CC幸存者中FSD的患病率显著高于对照组（分别为34.5%和10.4%）。与对照组相比，CC幸存者在润滑、性满意度和疼痛方面的报告结果明显更差。
CC幸存者组和对照组的患病率分别为34.5%和10.4%。与对照组相比，FSFI六个领域中的三个，即润滑、满意度和疼痛，在CC幸存者中表现出更多问题。
